COHANCE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- COHANCE
- MB Code
- MBEQU5396
- ISIN
- INE03QK01018
- BSE code
- 543064
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 619.12 Cr
- Net profit
- 8.31 Cr
- EPS
- 0.5
- YoY revenue
- +54.00%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for COHANCE
Cohance Lifesciences said Q4 net profit fell 83.8% to ₹20 crore and revenue declined 26.3% to ₹619.1 crore; it expects recovery only from…
EPS 0.92 vs est. 1.49
Missed estimates by 38.22%
Cohance Lifesciences rose 20% after appointing former Cipla CEO Umang Vohra as Executive Chairman from May 1, 2026 and Group CEO from May…
EPS 1.09 vs est. 3.24
Missed estimates by 66.40%
EPS 1.93 vs est. 1.53
Beat estimates by 26.14%
EPS 1.48 vs est. 1.62
Missed estimates by 8.74%
Price returns
Historical performance
Technicals
Indicator consensus